Two inexpensive supplements, CoQ10 and selenium, were linked to a drop in cardiovascular deaths from 12.6% to 5.9% in elderly Swedes. Heart-strain biomarkers and echocardiograms improved as well. But the trial enrolled just 443 people in a selenium-poor country, and it can't say which nutrient did the work. Here's what the KiSel-10 study actually showed, who it may apply to, and the safety limits to know before you try it.
This page is available in